← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 7, 2003Last known activity
Sep 30, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 11 trials)
Phase 4 (4 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Recent trials (19)
- NCT06569212CollaboratorPhase 4Sep 30, 2024
- NCT06569212Lead sponsorPhase 4Sep 30, 2024
- NCT06569212Sponsor investigatorPhase 4Sep 30, 2024
- NCT06569212OfficialPhase 4Sep 30, 2024
- NCT05428215Reponsible party - principal investigatorPhase 4Jun 30, 2023
- NCT05428215Lead sponsorPhase 4Jun 30, 2023
- NCT05428215Overall official - principal investigatorPhase 4Jun 30, 2023
- NCT05683808CollaboratorPhase 2Jan 16, 2023
- NCT05635916CollaboratorPhase 4Sep 22, 2022
- NCT05140499CollaboratorPhase 4Jan 3, 2022
- NCT05140499Sponsor investigatorPhase 4Jan 3, 2022
- NCT05140499Overall official - principal investigatorPhase 4Jan 3, 2022
- NCT04981678CollaboratorPhase 4Dec 1, 2021
- NCT04981678Sponsor investigatorPhase 4Dec 1, 2021
- NCT04827992CollaboratorN/ADec 1, 2021
Details
- Last known activity
- Sep 30, 2024